Intraoperative Transfusion of Packed Red Blood Cells in Microvascular Free Tissue Transfer Patients: Assessment of 30-Day Morbidity Using the NSQIP Dataset

被引:31
作者
Kim, Bobby D. [1 ]
Ver Halen, Jon P. [2 ]
Mlodinow, Alexei S. [3 ]
Kim, John Y. S. [3 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Plast Surg, Memphis, TN 38163 USA
[3] Northwestern Univ, Div Plast & Reconstruct Surg, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
transfusion; free flap; microsurgery; NSQIP; FREE-FLAP RECONSTRUCTION; OROPHARYNGEAL CANCER-SURGERY; QUALITY IMPROVEMENT PROGRAM; SURGICAL-SITE INFECTION; BREAST RECONSTRUCTION; HEMATOCRIT LEVELS; CARDIAC-SURGERY; POSTOPERATIVE MORBIDITY; KIDNEY-TRANSPLANTS; CRITICALLY-ILL;
D O I
10.1055/s-0033-1357275
中图分类号
R61 [外科手术学];
学科分类号
摘要
Although often a life-saving therapeutic maneuver, there is minimal data available that details the effects of intraoperative packed red blood cell transfusion (IOT) after microvascular free tissue transfer. The National Surgical Quality Improvement Program database was queried to identify all patients who underwent microvascular free tissue transfer between 2006 and 2010. Multivariate logistic regression models were used to determine the association between intraoperative transfusion and outcomes. Upon bivariate and multivariate analyses, IOT was significantly associated with higher rates of overall complications (odds ratio [OR], 2.02; 95% confidence interval [CI], 1.12-3.63), medical complications (OR, 3.35; 95% CI, 1.75-6.42), postoperative transfusion (OR, 6.02; 95% CI, 2.02-17.97), and reoperation (OR, 2.24; 95% CI, 1.24-4.04). IOT was not associated with either surgical complications or free flap loss. IOT significantly increases risk for adverse overall and medical complications. However, IOT was not associated with surgical complications or free flap loss. Transfusion practices in the operating room should be reevaluated to improve overall outcomes.
引用
收藏
页码:103 / 113
页数:11
相关论文
共 76 条
  • [61] Transfusion criteria in free flap surgery
    Rossmiller, Sarah R.
    Cannady, Steven B.
    Ghanem, Tamer A.
    Wax, Mark K.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2010, 142 (03) : 359 - 364
  • [62] INTERNATIONAL SURVEY OF CURRENT MICROVASCULAR PRACTICES IN FREE TISSUE TRANSFER AND REPLANTATION SURGERY
    SALEMARK, L
    [J]. MICROSURGERY, 1991, 12 (04) : 308 - 311
  • [63] SHAW WW, 1983, CLIN PLAST SURG, V10, P3
  • [64] An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery
    Slappendel, R
    Dirksen, R
    Weber, EWG
    van der Schaaf, DB
    [J]. ACTA ORTHOPAEDICA SCANDINAVICA, 2003, 74 (05): : 569 - 575
  • [65] The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma
    Szakmany, T
    Dodd, M
    Dempsey, GA
    Lowe, D
    Brown, JS
    Vaughan, ED
    Rogers, SN
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (05) : 647 - 653
  • [66] The efficacy of autologous cord-blood transfusions in neonatal surgical patients
    Taguchi, T
    Suita, S
    Nakamura, M
    Yamanouchi, T
    Ogita, K
    Taguchi, S
    Uesugi, T
    Nakano, H
    Inaba, S
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2003, 38 (04) : 604 - 607
  • [67] Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient
    Taylor, RW
    Manganaro, L
    O'Brien, J
    Trottier, SJ
    Parkar, N
    Veremakis, C
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (10) : 2249 - 2254
  • [68] Predictors of Blood Transfusion in Deep Inferior Epigastric Artery Perforator Flap Breast Reconstruction
    Ting, Jeannette
    Rozen, Warren M.
    Le Roux, Cara Michelle
    Ashton, Mark W.
    Garcia-Tutor, Emilio
    [J]. JOURNAL OF RECONSTRUCTIVE MICROSURGERY, 2011, 27 (04) : 233 - 237
  • [69] Perioperative allogenic blood transfusions and the risk of endometrial cancer recurrence
    Uccella, Stefano
    Ghezzi, Fabio
    Cromi, Antonella
    Bogani, Giorgio
    Formenti, Giorgio
    Donadello, Nicoletta
    Serati, Maurizio
    Bolis, Pierfrancesco
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 287 (05) : 1009 - 1016
  • [70] Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?
    Vamvakas, EC
    Blajchman, MA
    [J]. BLOOD, 2001, 97 (05) : 1180 - 1195